Literature DB >> 29049933

Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: A nationwide population-based cohort study.

Ling-Yi Wang1, Jen-Huai Chiang2, Shih-Fen Chen3, Yu-Chih Shen4.   

Abstract

BACKGROUND: Studies suggested autoimmunity plays a role in the etiology of bipolar disorder (BD). This study aimed to investigate the association between systemic autoimmune diseases (SADs) and the subsequent development of BD, and examine the potential risk factors for developing BD.
METHODS: Patients with SADs were identified in the Taiwan National Health Insurance Program (NHIP). A comparison cohort was created by matching patients without SADs with age. The SADs cohort consisted of 65,498 while the comparison cohort consisted of 261,992 patients. The incidence of BD was evaluated in both cohorts.
RESULTS: The major finding was the discovery of a higher incidence of subsequent BD among patients with SADs (adjusted hazard ratio: 1.98). Specifically, the risk of BD was observed to be significant increase in systemic lupus erythematosus, rheumatoid arthritis, autoimmune vasculitis, Sicca syndrome and Crohn's disease. Furthermore, our study revealed some potential risk factors for developing BD including female, younger age and patients who lived in eastern Taiwan. Also, some comorbidities including dyslipidemia, chronic obstructive pulmonary disease, diabetes mellitus, asthma, cerebrovascular disease, alcohol used disorder, liver cirrhosis, and malignancies were potential risk factors for incident BD. LIMITATIONS: The diagnosis of SADs was based on the catastrophic illness certificate defined by Taiwanese NHIP. Thus, not every form of SADs was explored for subsequent developing BD.
CONCLUSION: This study confirms that SADs are associated with higher incidence of BD, suggesting that abnormal autoimmune process is associated with increased expression of psychiatric disturbances.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder (BD); Systemic autoimmune diseases (SADs)

Mesh:

Year:  2017        PMID: 29049933     DOI: 10.1016/j.jad.2017.10.027

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats.

Authors:  Rachel Shvartsur; Galila Agam; Sarit Uzzan; Abed N Azab
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

2.  Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data.

Authors:  Min-Chih Hsieh; Chia-Wen Hsu; Ming-Chi Lu; Malcolm Koo
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

3.  Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated.

Authors:  Marjolein A M Sneeboer; Gijsje J L J Snijders; Woutje M Berdowski; Alba Fernández-Andreu; Hans C van Mierlo; Amber Berdenis van Berlekom; Manja Litjens; René S Kahn; Elly M Hol; Lot D de Witte
Journal:  Transl Psychiatry       Date:  2019-05-24       Impact factor: 6.222

4.  Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy.

Authors:  Michael P Pender
Journal:  Clin Transl Immunology       Date:  2020-04-06

5.  Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment.

Authors:  Alessandro Cuomo; Despoina Koukouna; Alessandro Spiti; Giovanni Barillà; Arianna Goracci; Simone Bolognesi; Andrea Fagiolini
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

Review 6.  Burden of pemphigus vulgaris with a particular focus on women: A review.

Authors:  Nika Kianfar; Shayan Dasdar; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Int J Womens Dermatol       Date:  2022-10-03

7.  Case Report: Psychopathological Syndromes in the Course of Lupus Erythematosus and the Co-occurrence of Lupus Erythematous With Mental Disorders.

Authors:  Ewa Stelmach; Jolanta Masiak
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

8.  Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review.

Authors:  Emma Kopra; Valeria Mondelli; Carmine Pariante; Naghmeh Nikkheslat
Journal:  J Psychopharmacol       Date:  2021-06-26       Impact factor: 4.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.